Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis-Reference-Cited by-同舟云学术

Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis

Published:2018-06-01 Issue:6 Volume:13 Page:e0197825
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Della Bella Chiara,Spinicci Michele,Grassi Alessia,Bartalesi Filippo,Benagiano Marisa,Truthmann Katja,Tapinassi Simona,Troilo Arianna,D’Elios Sofia,Alnwaisri Heba,Shuralev Eduard^ORCID,Singh Mahavir,Bartoloni Alessandro,D’Elios Mario Milco^ORCID

Funder

FP7 EU project DEMO-NOPERSIST

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. World Health Organization. Global Tuberculosis report 2017. Available from: http://www.who.int/tb/publications/global_report/en/

2. World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva, 2015. Available from: http://www.who.int/tb/publications/latent-tuberculosis-infection/en/

3. Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms;NK Dutta;Microbiol Mol Biol Rev,2014

4. Latent Mycobacterium tuberculosis infection;H Getahun;N Engl J Med,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved ELISPOT protocol for monitoring Th1/Th17 T-cell response following T.gondii infection;PLOS ONE;2024-05-08

2. The Applications of ELISpot in the Identification and Treatment of Various Forms of Tuberculosis and in the Cancer Immunotherapies;Methods in Molecular Biology;2024

3. Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection;Pharmaceutics;2023-09-30

4. Interleukin 4 gene polymorphisms and the risk of tuberculosis: A meta-analysis;Cytokine;2023-09

5. The Role of Interferon-Gamma Release Assays in Diagnosis of Latent Tuberculosis Infection in Children;Acta Clinica Croatica;2023